Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities.
Eur J Med Chem
; 244: 114833, 2022 Dec 15.
Article
in En
| MEDLINE
| ID: mdl-36228413
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B virus
/
Hepatitis B
Limits:
Humans
Language:
En
Journal:
Eur J Med Chem
Year:
2022
Document type:
Article
Country of publication:
France